133 related articles for article (PubMed ID: 24630047)
1. Short-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: a prospective study.
Dinopoulos A; Attilakos A; Paschalidou M; Tsirouda M; Garoufi A; Moustaki M; Siafakas N; Papaevangelou V
Epilepsy Res; 2014 May; 108(4):820-3. PubMed ID: 24630047
[TBL] [Abstract][Full Text] [Related]
2. Long-term effect of levetiracetam monotherapy on haematological parameters in children with epilepsy: A prospective study.
Attilakos A; Dinopoulos A; Paschalidou M; Tsirouda M; Karalexi M; Prasouli A; Garoufi A
Epilepsy Res; 2018 Sep; 145():160-162. PubMed ID: 30007241
[TBL] [Abstract][Full Text] [Related]
3. Haematological side effects of antiepileptic drug treatment in patients with epilepsy.
Bachmann T; Bertheussen KH; Svalheim S; Rauchenzauner M; Luef G; Gjerstad L; Taubøll E
Acta Neurol Scand Suppl; 2011; (191):23-7. PubMed ID: 21711253
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of levetiracetam efficacy in epileptic syndromes with continuous spikes-waves during slow sleep.
Atkins M; Nikanorova M
Seizure; 2011 Oct; 20(8):635-9. PubMed ID: 21752673
[TBL] [Abstract][Full Text] [Related]
5. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.
Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A
Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589
[TBL] [Abstract][Full Text] [Related]
6. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
Gao ZJ; Jiang YW
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.
Coppola G; Franzoni E; Verrotti A; Garone C; Sarajlija J; Operto FF; Pascotto A
Brain Dev; 2007 Jun; 29(5):281-4. PubMed ID: 17055681
[TBL] [Abstract][Full Text] [Related]
9. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
10. Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.
von Stuelpnagel C; Holthausen H; Kluger G
Eur J Paediatr Neurol; 2007 Nov; 11(6):341-5. PubMed ID: 17442601
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
12. Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Joo EY; Kim D; Hong SB
Epilepsy Res; 2013 Mar; 104(1-2):134-9. PubMed ID: 23032070
[TBL] [Abstract][Full Text] [Related]
13. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients.
Koo DL; Hwang KJ; Kim D; Kim YJ; Kim JY; Shin W; Kim MR; Joo EY; Lee JM; Hong SB
Eur Neurol; 2013; 70(1-2):88-94. PubMed ID: 23839084
[TBL] [Abstract][Full Text] [Related]
14. Retention rate of levetiracetam in children with intractable epilepsy at 1 year.
Peake D; Mordekar S; Gosalakkal J; Mukhtyar B; Buch S; Crane J; Wheway R; Rittey C; Donnelly J; Whitehouse WP; Philip S
Seizure; 2007 Mar; 16(2):185-9. PubMed ID: 17258474
[TBL] [Abstract][Full Text] [Related]
15. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
16. Hair loss with levetiracetam in five patients with epilepsy.
Zou X; Hong Z; Zhou D
Seizure; 2014 Feb; 23(2):158-60. PubMed ID: 24315496
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy.
Kanemura H; Sano F; Tando T; Sugita K; Aihara M
Brain Dev; 2013 May; 35(5):386-91. PubMed ID: 22871391
[TBL] [Abstract][Full Text] [Related]
19. Saliva and serum levetiracetam concentrations in patients with epilepsy.
Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
Verrotti A; Coppola G; Manco R; Ciambra G; Iannetti P; Grosso S; Balestri P; Franzoni E; Chiarelli F
Seizure; 2007 Apr; 16(3):271-5. PubMed ID: 17204435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]